DESCX
Price
$21.61
Change
-$0.25 (-1.14%)
Updated
Jun 13 closing price
Net Assets
253.23M
RWMEX
Price
$61.49
Change
-$0.63 (-1.01%)
Updated
Jun 13 closing price
Net Assets
196.45B
Interact to see
Advertisement

DESCX vs RWMEX

Header iconDESCX vs RWMEX Comparison
Open Charts DESCX vs RWMEXBanner chart's image
DWS ESG Core Equity C
Price$21.61
Change-$0.25 (-1.14%)
VolumeN/A
Net Assets253.23M
American Funds Washington Mutual R4
Price$61.49
Change-$0.63 (-1.01%)
VolumeN/A
Net Assets196.45B
DESCX vs RWMEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DESCX vs. RWMEX commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DESCX is a Buy and RWMEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWMEX has more cash in the bank: 196B vs. DESCX (253M). RWMEX pays higher dividends than DESCX: RWMEX (1.21) vs DESCX (0.00). DESCX was incepted earlier than RWMEX: DESCX (20 years) vs RWMEX (23 years). DESCX (1.74) is less costly to investors than RWMEX (0.61). RWMEX is a more actively managed with annual turnover of: 31.00 vs. DESCX (9.00). RWMEX has a lower initial minimum investment than DESCX: RWMEX (250) vs DESCX (1000). RWMEX annual gain was more profitable for investors over the last year : 4.29 vs. DESCX (-0.59). DESCX return over 5 years is better than : 58.93 vs. RWMEX (50.15).
DESCXRWMEXDESCX / RWMEX
Total Expense Ratio1.550.61254%
Annual Report Gross Expense Ratio1.740.61285%
Fund Existence20 years23 years-
Gain YTD0.1371.31010%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets253M196B0%
Annual Yield % from dividends0.001.21-
Returns for 1 year-0.594.29-14%
Returns for 3 years42.9923.79181%
Returns for 5 years58.9350.15117%
Returns for 10 years16.3258.8928%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EQIX892.64-3.78
-0.42%
Equinix
AVTX4.84-0.04
-0.82%
Avalo Therapeutics
HUMA2.37-0.04
-1.66%
Humacyte
XPEL36.22-0.80
-2.16%
XPEL
RMBS58.10-2.56
-4.22%
Rambus